Cargando…
Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia
Owing to advances in treatment modalities and supportive care, overall survival rates have reached up to 90% among children with acute lymphoblastic leukemia (ALL). However, due to the underlying illness and therapy, they are at a greater risk of developing lifestyle diseases. Hence, special attenti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998892/ https://www.ncbi.nlm.nih.gov/pubmed/35409072 http://dx.doi.org/10.3390/ijms23073712 |
_version_ | 1784685051583135744 |
---|---|
author | Konończuk, Katarzyna Muszyńska-Rosłan, Katarzyna Konstantynowicz-Nowicka, Karolina Krawczuk-Rybak, Maryna Chabowski, Adrian Latoch, Eryk |
author_facet | Konończuk, Katarzyna Muszyńska-Rosłan, Katarzyna Konstantynowicz-Nowicka, Karolina Krawczuk-Rybak, Maryna Chabowski, Adrian Latoch, Eryk |
author_sort | Konończuk, Katarzyna |
collection | PubMed |
description | Owing to advances in treatment modalities and supportive care, overall survival rates have reached up to 90% among children with acute lymphoblastic leukemia (ALL). However, due to the underlying illness and therapy, they are at a greater risk of developing lifestyle diseases. Hence, special attention is paid to early detection of the components of metabolic syndrome (MetS). This study aimed at investigating the association of plasma levels of nine diabetes markers with being overweight and components of MetS in ALL survivors. The study included 56 subjects with mean age of 12.36 ± 5.15 years. The commercially available Bio-Plex Pro Human Diabetes 10-Plex Panel kit was used to evaluate levels of diabetes biomarkers. ALL survivors presented statistically higher concentrations of GIP (p = 0.026), glucagon (p = 0.001), leptin (p = 0.022), and PAI-1 (p = 0.047), whereas the concentration of ghrelin was lower (p < 0.001) compared to the control group. Moreover, subjects within normal BMI range showed higher GIP (p = 0.005) and lower ghrelin concentration (p < 0.001) compared to healthy peers. At least one risk factor of MetS was present in 58.9% of participants, who showed significantly higher levels of C-peptide (p = 0.028), leptin (p = 0.003), and PAI-1 (p = 0.034) than survivors who did not meet any MetS criteria. In conclusion, ALL survivors are at greater risk of disturbances in carbohydrate metabolism. Understanding the pathogenesis and applicability of diabetes markers is crucial for developing strategies to prevent metabolic syndrome in ALL survivors. |
format | Online Article Text |
id | pubmed-8998892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89988922022-04-12 Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia Konończuk, Katarzyna Muszyńska-Rosłan, Katarzyna Konstantynowicz-Nowicka, Karolina Krawczuk-Rybak, Maryna Chabowski, Adrian Latoch, Eryk Int J Mol Sci Article Owing to advances in treatment modalities and supportive care, overall survival rates have reached up to 90% among children with acute lymphoblastic leukemia (ALL). However, due to the underlying illness and therapy, they are at a greater risk of developing lifestyle diseases. Hence, special attention is paid to early detection of the components of metabolic syndrome (MetS). This study aimed at investigating the association of plasma levels of nine diabetes markers with being overweight and components of MetS in ALL survivors. The study included 56 subjects with mean age of 12.36 ± 5.15 years. The commercially available Bio-Plex Pro Human Diabetes 10-Plex Panel kit was used to evaluate levels of diabetes biomarkers. ALL survivors presented statistically higher concentrations of GIP (p = 0.026), glucagon (p = 0.001), leptin (p = 0.022), and PAI-1 (p = 0.047), whereas the concentration of ghrelin was lower (p < 0.001) compared to the control group. Moreover, subjects within normal BMI range showed higher GIP (p = 0.005) and lower ghrelin concentration (p < 0.001) compared to healthy peers. At least one risk factor of MetS was present in 58.9% of participants, who showed significantly higher levels of C-peptide (p = 0.028), leptin (p = 0.003), and PAI-1 (p = 0.034) than survivors who did not meet any MetS criteria. In conclusion, ALL survivors are at greater risk of disturbances in carbohydrate metabolism. Understanding the pathogenesis and applicability of diabetes markers is crucial for developing strategies to prevent metabolic syndrome in ALL survivors. MDPI 2022-03-28 /pmc/articles/PMC8998892/ /pubmed/35409072 http://dx.doi.org/10.3390/ijms23073712 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Konończuk, Katarzyna Muszyńska-Rosłan, Katarzyna Konstantynowicz-Nowicka, Karolina Krawczuk-Rybak, Maryna Chabowski, Adrian Latoch, Eryk Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia |
title | Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia |
title_full | Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia |
title_fullStr | Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia |
title_full_unstemmed | Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia |
title_short | Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia |
title_sort | biomarkers of glucose metabolism alterations and the onset of metabolic syndrome in survivors of childhood acute lymphoblastic leukemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998892/ https://www.ncbi.nlm.nih.gov/pubmed/35409072 http://dx.doi.org/10.3390/ijms23073712 |
work_keys_str_mv | AT kononczukkatarzyna biomarkersofglucosemetabolismalterationsandtheonsetofmetabolicsyndromeinsurvivorsofchildhoodacutelymphoblasticleukemia AT muszynskarosłankatarzyna biomarkersofglucosemetabolismalterationsandtheonsetofmetabolicsyndromeinsurvivorsofchildhoodacutelymphoblasticleukemia AT konstantynowicznowickakarolina biomarkersofglucosemetabolismalterationsandtheonsetofmetabolicsyndromeinsurvivorsofchildhoodacutelymphoblasticleukemia AT krawczukrybakmaryna biomarkersofglucosemetabolismalterationsandtheonsetofmetabolicsyndromeinsurvivorsofchildhoodacutelymphoblasticleukemia AT chabowskiadrian biomarkersofglucosemetabolismalterationsandtheonsetofmetabolicsyndromeinsurvivorsofchildhoodacutelymphoblasticleukemia AT latocheryk biomarkersofglucosemetabolismalterationsandtheonsetofmetabolicsyndromeinsurvivorsofchildhoodacutelymphoblasticleukemia |